The deal will help the company advance its lead candidate into clinical trials.
(NYSE American: BURU), a dual-use Defense & Security platform company focused on non-kinetic effects, directed-energy technologies, electronic warfare and software-orchestrated defense systems, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results